Zobrazeno 1 - 10
of 138
pro vyhledávání: '"A. M. Rabasco"'
Publikováno v:
The Scientific World Journal, Vol 2012 (2012)
Formulation process is a very complex activity which sometimes implicates taking decisions about parameters or variables to obtain the best results in a high variability or uncertainty context. Therefore, robust optimization tools can be very useful
Externí odkaz:
https://doaj.org/article/bc86c27e8b854d3386112f4a35e1c73b
Autor:
Carmen M. Arroyo-García, Daniela Quinteros, Santiago D. Palma, Cesáreo J. Jiménez de los Santos, José R. Moyano, Antonio M. Rabasco, María Luisa González-Rodríguez
Publikováno v:
Pharmaceutics, Vol 13, Iss 12, p 2010 (2021)
The purpose of this study was to design, for the first time, a co-loaded liposomal formulation (CLL) for treatment of glaucoma including timolol maleate (TM) in the lipid bilayer and acetazolamide (Acz)-(2-hydroxy)propyl β-cyclodextrin (HPβCD) comp
Externí odkaz:
https://doaj.org/article/75d819ac24594a6b8e509c9de4628a97
Autor:
Mónica C. García, Nabila Naitlho, José Manuel Calderón-Montaño, Estrella Drago, Manuela Rueda, Marcela Longhi, Antonio M. Rabasco, Miguel López-Lázaro, Francisco Prieto-Dapena, María Luisa González-Rodríguez
Publikováno v:
Pharmaceutics, Vol 13, Iss 7, p 973 (2021)
Stimulus-responsive liposomes (L) for triggering drug release to the target site are particularly useful in cancer therapy. This research was focused on the evaluation of the effects of cholesterol levels in the performance of gold nanoparticles (AuN
Externí odkaz:
https://doaj.org/article/5f78984953d140a8b71247b234285993
Autor:
Azahara Rodríguez-Luna, Javier Ávila-Román, María Luisa González-Rodríguez, María José Cózar, Antonio M Rabasco, Virginia Motilva, Elena Talero
Publikováno v:
Marine Drugs, Vol 16, Iss 10, p 378 (2018)
Microalgae represent a source of bio-active compounds such as carotenoids with potent anti-inflammatory and antioxidant properties. We aimed to investigate the effects of fucoxanthin (FX) in both in vitro and in vivo skin models. Firstly, its anti-in
Externí odkaz:
https://doaj.org/article/c6cf3b7de9f44186ade267985c5ff8a3
Autor:
Ana-María, Fernández-Romero, Francesca, Maestrelli, Sara, García-Gil, Elena, Talero, Paola, Mura, Antonio M, Rabasco, María Luisa, González-Rodríguez
Publikováno v:
International Journal of Molecular Sciences
Curcumin (Cur) is an anti-inflammatory polyphenol that can be complexed with polymeric cyclodextrin (CD) to improve solubility and bioavailability. The aim of the present work was to prepare a CurCD hydrogel to treat inflammatory skin conditions. Epi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e868e091e92683559a6d8e9f4eb5e109
https://pubmed.ncbi.nlm.nih.gov/34948364
https://pubmed.ncbi.nlm.nih.gov/34948364
Autor:
Azahara Rodríguez-Luna, Elena Talero, María del Carmen Terencio, María Luisa González-Rodríguez, Antonio M. Rabasco, Carolina de los Reyes, Virginia Motilva, Javier Ávila-Román
Publikováno v:
Marine Drugs, Vol 16, Iss 1, p 2 (2017)
Chronic inflammatory skin diseases such as psoriasis have a significant impact on society. Currently, the major topical treatments have many side effects, making their continued use in patients difficult. Microalgae have emerged as a source of bio-ac
Externí odkaz:
https://doaj.org/article/07e969c4753a4aae800f6b88a0ce8327
Autor:
M.L. González-Rodríguez, Azahara Rodríguez-Luna, Antonio M. Rabasco, Virginia Motilva, Javier Ávila-Román, Elena Talero, Ana María Fernández Romero
Publikováno v:
AAPS PharmSciTech. 22
The topical use of rosmarinic acid (RA) in skin inflammatory pathologies is restricted due to its poor water solubility, poor permeability, and chemical instability. In this study, RA-loaded transethosomes-in-Carbopol® formulations have been develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cac0712f6c574b16b1975a78cd317656
https://doi.org/10.1208/s12249-021-01966-3
https://doi.org/10.1208/s12249-021-01966-3
Autor:
Antonio M. Rabasco, M.L. González-Rodríguez, J. R. Moyano, Carmen M. Arroyo-García, Santiago Daniel Palma, Cesáreo J. Jiménez de los Santos, Daniela Alejandra Quinteros
Publikováno v:
Pharmaceutics; Volume 13; Issue 12; Pages: 2010
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Pharmaceutics, Vol 13, Iss 2010, p 2010 (2021)
Pharmaceutics
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Pharmaceutics, Vol 13, Iss 2010, p 2010 (2021)
Pharmaceutics
The purpose of this study was to design, for the first time, a co-loaded liposomal formulation (CLL) for treatment of glaucoma including timolol maleate (TM) in the lipid bilayer and acetazolamide (Acz)-(2-hydroxy)propyl β-cyclodextrin (HPβCD) comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4039057d41fc8130c11d2b369d80b535
Autor:
Paola Mura, Carla Ghelardini, M.L. González-Rodríguez, Lorenzo Di Cesare Mannelli, Francesca Maestrelli, Ana-María Fernández-Romero, Laura Micheli, Antonio M. Rabasco
Publikováno v:
The 1st International Electronic Conference on Pharmaceutics.
Osteoarthritis (OA) is one of the most frequent degenerative joint diseases characterized by joint pain and stiffness traditionally treated with symptomatic drugs such as oral nonsteroidal anti-inflammatory drugs (NSAIDs )and, in extreme cases, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::640157cb8f73b13d3b93ddd6690f04f7
https://doi.org/10.3390/iecp2020-08720
https://doi.org/10.3390/iecp2020-08720
Publikováno v:
Ars Pharmaceutica (Internet) v.61 n.2 2020
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)
Ars Pharmaceutica (Internet), Volume: 61, Issue: 2, Pages: 81-96, Published: 29 JUN 2020
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Ars Pharmaceutica, Vol 61, Iss 2, Pp 81-96 (2020)
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)
Ars Pharmaceutica (Internet), Volume: 61, Issue: 2, Pages: 81-96, Published: 29 JUN 2020
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Ars Pharmaceutica, Vol 61, Iss 2, Pp 81-96 (2020)
Introducción: Actualmente, los tratamientos existentes para tratar la fibrosis quística (FQ) están diseñados para controlar sus síntomas, consistentes principalmente en retención de moco e infección crónica. Se propone la vía pulmonar como a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a0535d41ba7173302c1f9d6cf72222bc